Fate Therapeutics (FATE) Other Non-Current Liabilities (2016 - 2025)
Historic Other Non-Current Liabilities for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to $6.6 million.
- Fate Therapeutics' Other Non-Current Liabilities rose 23969.07% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year increase of 23969.07%. This contributed to the annual value of $5.1 million for FY2024, which is 27667.16% up from last year.
- Fate Therapeutics' Other Non-Current Liabilities amounted to $6.6 million in Q3 2025, which was up 23969.07% from $5.6 million recorded in Q2 2025.
- Over the past 5 years, Fate Therapeutics' Other Non-Current Liabilities peaked at $24.6 million during Q3 2021, and registered a low of $701000.0 during Q3 2023.
- Its 5-year average for Other Non-Current Liabilities is $7.7 million, with a median of $5.1 million in 2024.
- Per our database at Business Quant, Fate Therapeutics' Other Non-Current Liabilities skyrocketed by 152848.1% in 2021 and then crashed by 9224.3% in 2023.
- Fate Therapeutics' Other Non-Current Liabilities (Quarter) stood at $24.2 million in 2021, then tumbled by 84.02% to $3.9 million in 2022, then tumbled by 65.14% to $1.3 million in 2023, then skyrocketed by 276.67% to $5.1 million in 2024, then increased by 29.98% to $6.6 million in 2025.
- Its Other Non-Current Liabilities was $6.6 million in Q3 2025, compared to $5.6 million in Q2 2025 and $5.1 million in Q1 2025.